Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A List

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Journal of Health Economics|July 23, 2013
Consumers' misunderstanding of health insuranceGeorge Loewenstein, Joelle Y Friedman, Barbara McGill, et al.
Head & Neck|April 3, 2023
Tumor volume as a predictor of survival in advanced laryngeal cancer treated with total laryngectomyKrishna S Hanubal, Zhanna Galochkina, Ji-Hyun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancerDaniel J Haraf, Fred R Rosen, Kerstin Stenson, et al.
Leukemia|January 19, 2017
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858E A Eksioglu, X Chen, K-H Heider, et al.
Leukemia|January 24, 2017
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research ConsortiumA M Zeidan, N Al Ali, J Barnard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialEzra E W Cohen, Daniel J Haraf, Marcy A List, et al.
Leukemia|May 21, 2015
Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progressionA Pellagatti, S Roy, C Di Genua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study GroupP Greenberg, J Anderson, T de Witte, et al.
International Journal of Oncology|April 6, 2006
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directionsMichael T Milano, Everett E Vokes, Johnny Kao, et al.
Bone Marrow Transplantation|October 6, 2000
A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphomaP Stiff, R Gingrich, S Luger, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Journal of Health Economics|July 23, 2013
Consumers' misunderstanding of health insuranceGeorge Loewenstein, Joelle Y Friedman, Barbara McGill, et al.
Head & Neck|April 3, 2023
Tumor volume as a predictor of survival in advanced laryngeal cancer treated with total laryngectomyKrishna S Hanubal, Zhanna Galochkina, Ji-Hyun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2003
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancerDaniel J Haraf, Fred R Rosen, Kerstin Stenson, et al.
Leukemia|January 19, 2017
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858E A Eksioglu, X Chen, K-H Heider, et al.
Leukemia|January 24, 2017
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research ConsortiumA M Zeidan, N Al Ali, J Barnard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2006
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trialEzra E W Cohen, Daniel J Haraf, Marcy A List, et al.
Leukemia|May 21, 2015
Targeted resequencing analysis of 31 genes commonly mutated in myeloid disorders in serial samples from myelodysplastic syndrome patients showing disease progressionA Pellagatti, S Roy, C Di Genua, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2000
Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study GroupP Greenberg, J Anderson, T de Witte, et al.
International Journal of Oncology|April 6, 2006
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directionsMichael T Milano, Everett E Vokes, Johnny Kao, et al.
Bone Marrow Transplantation|October 6, 2000
A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphomaP Stiff, R Gingrich, S Luger, et al.
Pageof 16